Wieneke M. T. van den Hombergh

Survival and organ involvement in patients with limited cutaneous systemic sclerosis and anti-topoisomerase-I antibodies: determined by skin subtype or auto-antibody subtype? A long-term follow-up study

Pim Kranenburg, Wieneke M. T. van den Hombergh, Hanneke K. A. Knaapen‐Hans et al. · Lara D. Veeken · 2016 · 40 citations · Full text

Prediction of organ involvement and survival in systemic sclerosis patients in the first 5 years from diagnosis

Wieneke M. T. van den Hombergh, Hanneke K. A. Knaapen‐Hans, F.H.J. van den Hoogen et al. · Journal of Scleroderma and Related Disorders · 2019 · 19 citations · Full text

Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function

Wieneke M. T. van den Hombergh, Sami O. Simons, E. Teesselink et al. · Clinical Rheumatology · 2018 · 18 citations · Full text

Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial

Wieneke M. T. van den Hombergh, Brigit E. Kersten, Hanneke K. A. Knaapen‐Hans et al. · Trials · 2018 · 18 citations · Full text

An easy prediction rule for diffuse cutaneous systemic sclerosis using only the timing and type of first symptoms and auto-antibodies: derivation and validation

Wieneke M. T. van den Hombergh, Patrícia Carreira, Hanneke K. A. Knaapen‐Hans et al. · Lara D. Veeken · 2016 · 12 citations · Full text